The Tech - Online EditionMIT's oldest and largest
newspaper & the first
newspaper published
on the web
Last Published: April 14, 2016
Boston Weather: 25.0°F | Overcast

Articles by Gardiner Harris

THE NEW YORK TIMES
January 23, 2013
NEW DELHI — Indian officials are advising residents of strife-torn Kashmir to prepare for a possible nuclear war by building bombproof basements and stockpiling food and water, adding to tensions between India and Pakistan, both nuclear powers, after deadly cross-border skirmishes in recent weeks.
THE NEW YORK TIMES
November 4, 2011
Federal drug officials Thursday claimed credit for an increase in the approval of new drugs and argued that the results demonstrated the need for legislation to continue financing the current drug approval system.
THE NEW YORK TIMES
August 26, 2011
Yet another panel of scientists has found no evidence that a popular vaccine causes autism. But despite the scientists’ best efforts, their report is unlikely to have any impact on the frustrating debate about the safety of these crucial medicines.
THE NEW YORK TIMES
November 6, 2007
Pressured by regulators, the German pharmaceutical giant Bayer AG announced on Monday that it had agreed to withdraw the controversial heart surgery drug Trasylol after a Canadian study suggested that it increased death rates.
THE NEW YORK TIMES
October 12, 2007
Major makers of over-the-counter infant cough and cold medicines announced Thursday that they were voluntarily withdrawing their products from the market for fear that they could be misused by parents.
THE NEW YORK TIMES
June 8, 2007
The government's top drug regulator told a packed House hearing Wednesday that the agency had recently decided to put the agency's most serious safety warning on two diabetes drugs — Avandia and Actos — whose health risks have become a focus of congressional concern.
<< First   1   Last >>